Clinical Trial Detail

Contact

Missing content? – Request curation!

Request curation for specific Genes, Variants, or PubMed publications.

Have questions, comments, or suggestions? - Let us know!

Email us at : ckbsupport@genomenon.com

NCT ID NCT01487265
Title Trial of Erlotinib and BKM120 in Patients With Advanced Non Small Cell Lung Cancer Previously Sensitive to Erlotinib
Recruitment Completed
Gender both
Phase Phase II
Variant Requirements No
Sponsors SCRI Development Innovations, LLC
Indications
Therapies
Age Groups: adult | senior
Covered Countries USA

Facility Status City State Zip Country Details
Florida Cancer Specialists South Fort Myers Florida 33916 United States Details
Florida Hospital Cancer Institute Orlando Florida 32804 United States Details
Florida Cancer Specialists North Saint Petersburg Florida 33705 United States Details
Florida Cancer Specialists East West Palm Beach Florida 33401 United States Details
Oncology Hematology Care, Inc. Cincinnati Ohio 45242 United States Details
Tennessee Oncology, PLLC Nashville Tennessee 37023 United States Details
Center for Cancer and Blood Disorders Fort Worth Texas 76104 United States Details
*Shaded cells indicate that there was no data available from clinicaltrials.gov for the field